
FDA approves Sanofi anticancer treatment delivered through Enable Injections on-body device
Sanofi announced today that the FDA approved the delivery of its Sarclisa anticancer therapy through the Enable Injections on-body device.

Sanofi announced today that the FDA approved the delivery of its Sarclisa anticancer therapy through the Enable Injections on-body device.

Thread-based electronics that conform to the body could point toward softer, less obtrusive health monitors

Zeta Surgical announced today that it received FDA 510(k) clearance for its TMS Robotic System as a stereotaxic instrument.

Spiro Robotics earned FDA 510(k) clearance for its handheld, dual image-guided system for tracheal intubation, Spiro-VISTA.

A high-performance biodegradable pressure sensor has been developed as a key technology for wearable AI health care robotics and user-friendly robotic systems.

Fertility declines as women get older for many reasons, such as a drop in egg quality, decreased follicle numbers and hardening of ovarian tissues.

Researchers at the University of Sheffield have discovered that a fungus deadly to people with weakened immune systems can disable a critical defense used by neutrophils, the body’s front-line, infection-fighting white blood cells.

A new platform developed by researchers at the University of Texas MD Anderson Cancer Center quickly finds and isolates rare, tumor-reactive immune cells that are especially good at recognizing and attacking cancer cells.

A research team led by Professor Il-Joo Cho of Korea University College of Medicine has developed a novel brain implant capable of bidirectionally modulating neural activity using temperature.

Researchers have solved a long-standing mystery of how abnormal chromosomes drive cancer, identifying 81 new genes involved in aggressive breast cancer.